Sarah Haecker Meeks
Plus aucun poste en cours
Profil
Sarah Haecker Meeks is a former Vice President of Business Development at BioErgonomics, Inc., Orasi Medical, Inc., and Synpromics Ltd.
She also served as the Chief Scientific Officer at Adjuvant Partners LLC.
In her most recent position, she was the Senior Vice President of Business Development at MaxCyte, Inc. Dr. Meeks holds an MBA from the University of Pennsylvania, an undergraduate degree from the University of Wisconsin, and a doctorate from the University of Minnesota.
Anciens postes connus de Sarah Haecker Meeks
Sociétés | Poste | Fin |
---|---|---|
MAXCYTE, INC. | Corporate Officer/Principal | 01/03/2024 |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Corporate Officer/Principal | 18/08/2012 |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Corporate Officer/Principal | - |
Adjuvant Partners LLC | Chief Tech/Sci/R&D Officer | - |
BioErgonomics, Inc.
BioErgonomics, Inc. Pharmaceuticals: MajorHealth Technology BioE, Inc. develops high quality, antibody-based technologies. The company commercializes human umbilical blood stem cells, associated tools, pharmaceuticals via high-quality cellular research, and drug discovery. BioE was founded in 1993 and is headquartered in St. Paul, MN. | Corporate Officer/Principal | - |
Formation de Sarah Haecker Meeks
University of Pennsylvania | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MAXCYTE, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
BioErgonomics, Inc.
BioErgonomics, Inc. Pharmaceuticals: MajorHealth Technology BioE, Inc. develops high quality, antibody-based technologies. The company commercializes human umbilical blood stem cells, associated tools, pharmaceuticals via high-quality cellular research, and drug discovery. BioE was founded in 1993 and is headquartered in St. Paul, MN. | Health Technology |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Process Industries |
Adjuvant Partners LLC |